Biomarkers for DNA DSB inhibitors and radiotherapy clinical trials
CANCER AND METASTASIS REVIEWS (2008)
期刊
CANCER AND METASTASIS REVIEWS
卷 27, 期 3, 页码 445-458出版社
SPRINGER
关键词
类别
资金
- National Cancer Institute of Canada
- Terry Fox Foundation
- Canadian Institutes of Health Research
作者
我是这篇论文的作者
推荐
DNA Protection by an Aronia Juice-Based Food Supplement
Tamara Bakuradze, Peter Meiser, Jens Galan, Elke Richling
ANTIOXIDANTS (2021)
DNA-PKcs restricts Zika virus spreading and is required for effective antiviral response
Daniel de Oliveira Patricio, Greicy Brisa Malaquias Dias, Lucilene Wildner Granella, Ben Trigg, Helena Claire Teague, Dina Bittencourt, Andre Bafica, Alfeu Zanotto-Filho, Brian Ferguson, Daniel Santos Mansur
FRONTIERS IN IMMUNOLOGY (2022)
ATR Contributes More Than ATM in Intra-S-Phase Checkpoint Activation after IR, and DNA-PKcs Facilitates Recovery: Evidence for Modular Integration of ATM/ATR/DNA-PKcs Functions
Aashish Soni, Xiaolu Duan, Martin Stuschke, George Iliakis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Assessing Genotoxicity of Ten Different Engineered Nanomaterials by the Novel Semi-Automated FADU Assay and the Alkaline Comet Assay
Sarah May, Cordula Hirsch, Alexandra Rippl, Alexander Buerkle, Peter Wick
NANOMATERIALS (2022)
DNA Double-Strand Breaks Induced in Human Cells by 6 Current Pesticides: Intercomparisons and Influence of the ATM Protein
Laurene Sonzogni, Melanie L. Ferlazzo, Adeline Granzotto, Beatrice Fervers, Laurent Charlet, Nicolas Foray
BIOMOLECULES (2022)
Shift in G1-Checkpoint from ATM-Alone to a Cooperative ATM Plus ATR Regulation with Increasing Dose of Radiation
Fanghua Li, Emil Mladenov, Rositsa Dueva, Martin Stuschke, Beate Timmermann, George Iliakis
CELLS (2022)
A deep learning model (FociRad) for automated detection of γ-H2AX foci and radiation dose estimation
Rujira Wanotayan, Khaisang Chousangsuntorn, Phasit Petisiwaveth, Thunchanok Anuttra, Waritsara Lertchanyaphan, Tanwiwat Jaikuna, Kulachart Jangpatarapongsa, Pimpon Uttayarat, Teerawat Tongloy, Chousak Chousangsuntorn, Siridech Boonsang
SCIENTIFIC REPORTS (2022)
Live-cell tracking of ?-H2AX kinetics reveals the distinct modes of ATM and DNA-PK in the immediate response to DNA damage
Watanya Trakarnphornsombat, Hiroshi Kimura
JOURNAL OF CELL SCIENCE (2023)
Unrepaired base excision repair intermediates in template DNA strands trigger replication fork collapse and PARP inhibitor sensitivity
Almudena Serrano-Benitez, Sophie E. Wells, Lylah Drummond-Clarke, Lilian C. Russo, John Christopher Thomas, Giovanna A. Leal, Mark Farrow, James Michael Edgerton, Shankar Balasubramanian, Ming Yang, Christian Frezza, Amit Gautam, Jan Brazina, Kamila Burdova, Nicolas C. Hoch, Stephen P. Jackson, Keith W. Caldecott
EMBO JOURNAL (2023)
DNA Double-Strand Breaks Induced in Human Cells by Twelve Metallic Species: Quantitative Inter-Comparisons and Influence of the ATM Protein
Muriel Viau, Laurene Sonzogni, Melanie L. Ferlazzo, Elise Berthel, Sandrine Pereira, Larry Bodgi, Adeline Granzotto, Clement Devic, Beatrice Fervers, Laurent Charlet, Nicolas Foray
BIOMOLECULES (2021)
HiIDDD: a high-throughput imaging pipeline for the quantitative detection of DNA damage in primary human immune cells
Kelsey Gallant, Arsun Bektas, Mary Kaileh, Ana Lustig, Luigi Ferrucci, Gianluca Pegoraro, Tom Misteli
SCIENTIFIC REPORTS (2022)
Application of the Fpg-modified comet assay on three-spined stickleback in freshwater biomonitoring: toward a multi-biomarker approach of genotoxicity
Amelie Cant, Anne Bado-Nilles, Jean-Marc Porcher, Dorothee Bolzan, Jean Prygiel, Audrey Catteau, Cyril Turies, Alain Geffard, Marc Bonnard
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2023)
Oocytes can repair DNA damage during meiosis via a microtubule-dependent recruitment of CIP2A-MDC1-TOPBP1 complex from spindle pole to chromosomes
Jiyeon Leem, Jae-Sung Kim, Jeong Su Oh
NUCLEIC ACIDS RESEARCH (2023)
The out-of-field dose in radiation therapy induces delayed tumorigenesis by senescence evasion
Erwan Goy, Maxime Tomezak, Caterina Facchin, Nathalie Martin, Emmanuel Bouchaert, Jerome Benoit, Clementine de Schutter, Joe Nassour, Laure Saas, Claire Drullion, Priscille M. Brodin, Alexandre Vandeputte, Olivier Molendi-Coste, Laurent Pineau, Gautier Goormachtigh, Olivier Pluquet, Albin Pourtier, Fabrizio Cleri, Eric Lartigau, Nicolas Penel, Corinne Abbadie
ELIFE (2022)
The H. pylori CagA Oncoprotein Induces DNA Double Strand Breaks through Fanconi Anemia Pathway Downregulation and Replication Fork Collapse
Arun Mouli Kolinjivadi, Haresh Sankar, Ramveer Choudhary, Lavina Sierra Tay, Tuan Zea Tan, Naoko Murata-Kamiya, Dominic Chih-Cheng Voon, Dennis Kappei, Masanori Hatakeyama, Vaidehi Krishnan, Yoshiaki Ito
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression
Ekaterina Olkhov-Mitsel, Anjelica Hodgson, Stanley K. Liu, Danny Vesprini, Bin Xu, Michelle R. Downes
JOURNAL OF CLINICAL PATHOLOGY (2022)
Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy
Matthew Ramotar, Melvin L. K. Chua, Hong Truong, Ali Hosni, Melania Pintilie, Elai Davicioni, Neil E. Fleshner, Adam P. Dicker, Robert G. Bristow, Hansen H. He, Theo van der Kwast, Robert B. Den, Alejandro Berlin
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)
Conversations with LGBT plus scientists about visibility, leadership and climbing the career ladder
Robert G. Bristow, Joanne Engel, Izzy Jayasinghe, Martin Kampmann, Owen James Sansom, David M. Bryant
JOURNAL OF CELL SCIENCE (2022)
Prostate zones and cancer: lost in transition?
Amin Ali, Alexander Du Feu, Pedro Oliveira, Ananya Choudhury, Robert G. Bristow, Esther Baena
NATURE REVIEWS UROLOGY (2022)
Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Rohann J. M. Correa, Gerard Morton, Hans T. Chung, Chia-Lin Tseng, Patrick Cheung, William Chu, Stanley K. Liu, Merrylee McGuffin, Anam Shahid, Melanie Davidson, Ananth Ravi, Joelle Helou, Yasir Alayed, Liying Zhang, Alexandre Mamedov, Andrew Loblaw
RADIOTHERAPY AND ONCOLOGY (2022)
Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer
Kevin Martell, Hans Chung, Gerard Morton, Danny Vesprini, Chia -Lin Tseng, Ewa Szumacher, Patrick Cheung, Will Chu, Stanley Liu, Andrew Loblaw
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2022)
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
Silke Gillessen, Andrew Armstrong, Gert Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Alberto Bossi, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Kim N. Chi, Caroline S. Clarke, Noel Clarke, Ian D. Davis, Johann S. de Bono, Ignacio Duran, Ros Eeles, Eleni Efstathiou, Jason Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Dan George, Martin Gleave, Susan Halabi, Daniel Heinrich, Celesta Higano, Michael S. Hofman, Maha Hussain, Nick James, Robert Jones, Ravindran Kanesvaran, Raja B. Khauli, Laurence Klotz, Raya Leibowitz, Chris Logothetis, Fernando Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind Mrabti, Declan G. Murphy, Vedang Murthy, William K. Oh, Piet Ost, Joe M. O'Sullivan, Anwar R. Padhani, Chris Parker, Darren M. C. Poon, Colin C. Pritchard, Danny M. Rabah, Dana Rathkopf, Rob E. Reiter, Mark Rubin, Charles J. Ryan, Fred Saad, Juan P. Sade, Oliver Sartor, Howard Scher, Neal Shore, Iwona Skoneczna, Eric Small, Matthew Smith, Howard Soule, Daniel E. Spratt, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher Sweeney, Matthew R. Sydes, Mary-Ellen Taplin, Derya Tilki, Bertrand Tombal, Levent Turkeri, Hiroji Uemura, Hirotsugu Uemura, Inge van Oort, Kosj Yamoah, Dingwei Ye, Almudena Zapatero, Aurelius Omlin
EUROPEAN UROLOGY (2022)
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study
Daniel Burns, Ezequiel Anokian, Edward J. Saunders, Robert G. Bristow, Michael Fraser, Juri Reimand, Thorsten Schlomm, Guido Sauter, Benedikt Brors, Jan Korbel, Joachim Weischenfeldt, Sebastian M. Waszak, Niall M. Corcoran, Chol-Hee Jung, Bernard J. Pope, Chris M. Hovens, Geraldine Cancel-Tassin, Olivier Cussenot, Massimo Loda, Chris Sander, Vanessa M. Hayes, Karina Dalsgaard Sorensen, Yong-Jie Lu, Freddie C. Hamdy, Christopher S. Foster, Vincent Gnanapragasam, Adam Butler, Andy G. Lynch, Charlie E. Massie, Dan J. Woodcock, Colin S. Cooper, David C. Wedge, Daniel S. Brewer, Zsofia Kote-Jarai, Rosalind A. Eeles
EUROPEAN UROLOGY (2022)
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer
C. E. Fletcher, L. Deng, F. Orafidiya, W. Yuan, M. P. G. S. Lorentzen, O. W. Cyran, A. Varela-Carver, T. A. Constantin, D. A. Leach, F. M. Dobbs, I Figueiredo, B. Gurel, E. Parkes, D. Bogdan, R. R. Pereira, S. G. Zhao, A. Neeb, F. Issa, J. Hester, H. Kudo, Y. Liu, Y. Philippou, R. Bristow, K. Knudsen, R. J. Bryant, F. Y. Feng, S. H. Reed, I. G. Mills, J. de Bono, C. L. Bevan
MOLECULAR CANCER (2022)
Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts
HoYin Lip, Mohammad Ali Amini, Abdulmottaleb Zetrini, Ping Cai, Azhar Z. Abbasi, Robert G. Bristow, Andrew Michael Rauth, Xiao Yu Wu
RADIOTHERAPY AND ONCOLOGY (2022)
RadBone: bone toxicity following pelvic radiotherapy - a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy
Victoria Chatzimavridou Grigoriadou, Lisa H. Barraclough, Ivona Baricevic-Jones, Robert G. Bristow, Martin Eden, Kate Haslett, Karen Johnson, Rohit Kochhar, Zoe Merchant, John Moore, Sarah O'Connell, Sally Taylor, Thomas Westwood, Anthony David Whetton, Janelle Yorke, Claire E. Higham
BMJ OPEN (2022)
Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion - Results from the 2SMART phase 2 trial
Wee Loon Ong, Patrick Cheung, Hans Chung, William Chu, Jay Detsky, Stanley Liu, Gerard Morton, Ewa Szumacher, Chia -Lin Tseng, Danny Vesprini, Melanie Davidson, Ananth Ravi, Merrylee McGuffin, Liying Zhang, Alexandre Mamedov, Andrea Deabreu, Meghan Kulasingham-Poon, Andrew Loblaw
RADIOTHERAPY AND ONCOLOGY (2023)
Ultrasound-stimulated microbubbles enhanced vascular disruption in fractionated radiotherapy-treated tumours via ASMase activation
Kai Xuan Leong, Wenyi Yang, Deepa Sharma, Stanley Liu, Gregory J. Czarnota
DISEASE MODELS & MECHANISMS (2023)
Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer
Wee Loon Ong, Melanie Davidson, Patrick Cheung, Hans Chung, William Chu, Jay Detsky, Stanley Liu, Gerard Morton, Ewa Szumacher, Chia-Lin Tseng, Danny Vesprini, Ananth Ravi, Merrylee Mcguffin, Liying Zhang, Alexandre Mamedov, Andrea Deabreu, Meghan Kulasingham-Poon, Andrew Loblaw
RADIOTHERAPY AND ONCOLOGY (2023)
Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer
Harry C. Brastianos, Jure Murgic, Adriana Salcedo, Melvin L. K. Chua, Alice Meng, Michael Fraser, Michael Brundage, Neil E. Fleshner, Theodorus van der Kwast, Robert G. Bristow, Paul C. Boutros, Alejandro Berlin
EUROPEAN UROLOGY ONCOLOGY (2022)